title: Inhibition of death receptor signals by cellular FLIP.
abstract: The widely expressed protein Fas is a member of the tumour necrosis factor receptor family which can trigger apoptosis. However, Fas surface expression does not necessarily render cells susceptible to Fas ligand-induced death signals, indicating that inhibitors of the apoptosis-signalling pathway must exist. Here we report the characterization of an inhibitor of apoptosis, designated FLIP (for FLICE-inhibitory protein), which is predominantly expressed in muscle and lymphoid tissues. The short form, FLIPs, contains two death effector domains and is structurally related to the viral FLIP inhibitors of apoptosis, whereas the long form, FLIP(L), contains in addition a caspase-like domain in which the active-centre cysteine residue is substituted by a tyrosine residue. FLIPs and FLIP(L) interact with the adaptor protein FADD and the protease FLICE, and potently inhibit apoptosis induced by all known human death receptors. FLIP(L) is expressed during the early stage of T-cell activation, but disappears when T cells become susceptible to Fas ligand-mediated apoptosis. High levels of FLIP(L) protein are also detectable in melanoma cell lines and malignant melanoma tumours. Thus FLIP may be implicated in tissue homeostasis as an important regulator of apoptosis.
authors.affiliation: Institute of Biochemistry, Lausanne branch, University of Lausanne, Switzerland.
authors.forename: M
authors.initials: M
authors.lastname: Irmler
authors.forename: M
authors.initials: M
authors.lastname: Thome
authors.forename: M
authors.initials: M
authors.lastname: Hahne
authors.forename: P
authors.initials: P
authors.lastname: Schneider
authors.forename: K
authors.initials: K
authors.lastname: Hofmann
authors.forename: V
authors.initials: V
authors.lastname: Steiner
authors.forename: J L
authors.initials: JL
authors.lastname: Bodmer
authors.forename: M
authors.initials: M
authors.lastname: Schröter
authors.forename: K
authors.initials: K
authors.lastname: Burns
authors.forename: C
authors.initials: C
authors.lastname: Mattmann
authors.forename: D
authors.initials: D
authors.lastname: Rimoldi
authors.forename: L E
authors.initials: LE
authors.lastname: French
authors.forename: J
authors.initials: J
authors.lastname: Tschopp
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000595:Amino Acid Sequence; D000818:Animals; D017209:Apoptosis; D053446:CASP8 and FADD-Like Apoptosis Regulating Protein; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D053181:Caspase 8; D053453:Caspase 9; D020169:Caspases; D002478:Cells, Cultured; D002889:Chromosomes, Human, Pair 2; D003001:Cloning, Molecular; D003546:Cysteine Endopeptidases / Q000378:metabolism; D053200:Fas-Associated Death Domain Protein; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008213:Lymphocyte Activation; D008545:Melanoma / Q000378:metabolism; D008969:Molecular Sequence Data; D017386:Sequence Homology, Amino Acid; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D014407:Tumor Cells, Cultured; D019014:fas Receptor / Q000378:metabolism
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D053446:CASP8 and FADD-Like Apoptosis Regulating Protein; C506386:CFLAR protein, human; D002352:Carrier Proteins; C505533:FADD protein, human; D053200:Fas-Associated Death Domain Protein; D047908:Intracellular Signaling Peptides and Proteins; D019014:fas Receptor; C505530:CASP8 protein, human; C506433:CASP9 protein, human; D053181:Caspase 8; D053453:Caspase 9; D020169:Caspases; D003546:Cysteine Endopeptidases